BENSALEM, Pa.–()–Law Offices of Howard G. Smith announces that investors of Dynavax Technologies Corporation (“Dynavax” or the “Company”) (NASDAQ:DVAX) have until August 19, 2013 to move the Court to serve as lead plaintiff in the securities fraud class action lawsuit filed in the United States District Court for the Northern District of California on behalf of a class (the “Class”) comprising all purchasers of Dynavax securities between April 26, 2012 and June 10, 2013, inclusive (the “Class Period”).
Dynavax discovers and develops novel products to prevent and treat infectious and inflammatory diseases. The Company’s product candidate, Heplisav, is a Phase 3 investigational adult hepatitis B vaccine. The Complaint alleges that during the Class Period the Company issued false and/or misleading statements and/or failed to disclose that: (1) the clinical trial for Heplisav was flawed because the trial demographics were not representative of the U.S. population; (2) the Heplisav clinical trial was lacking the one-year safety follow-up typically required for vaccines; (3) the trial was lacking information concerning concomitant use with other vaccines; (4) the clinical trial’s safety database was inadequate to rule out rare adverse autoimmune events; (5) Dynavax failed to provide the FDA with sufficient data on its concerning its manufacturing processes and controls for Heplisav; and (6) based on the foregoing, defendants lacked a reasonable basis for their positive statements about the Company’s outlook, including statements about its launch of Heplisav in 2013.
If you are a member of the Class described above, you have certain rights and have until August 19, 2013 to move for lead plaintiff status. To be a member of the class you need not take any action at this time, or may retain counsel of your choice. If you purchased shares prior to the Class Period or wish to learn more concerning your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to email@example.com, or visit our website at http://www.howardsmithlaw.com.